Thalidomide for treatment of severe generalized discoid lupus lesions in two patients with systemic lupus erythematosus.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12734488.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We describe 2 patients with systemic lupus erythematous whose widespread discoid lupus erythematosus was unresponsive to systemic steroids and antimalarial agents. They showed dramatic improvement to thalidomide at a dose of 300 mg/d, with maximum benefit achieved within 15 weeks of therapy. Dosages of 50 to 100 mg/d were effective in maintaining remission for 1 year. However, thalidomide-induced neuropathy was observed in both cases.
Medical subject headings
- Dermatologic Agents
- Lupus Erythematosus, Discoid
- Lupus Erythematosus, Systemic
- Thalidomide